Is there an antiaging medicine?

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 57, Issue 9, 2002, Pages B333-B338

  Butler, Robert N ^a   Fossel, Michael ^b   Harman, S Mitchell ^c   Heward, Christopher B ^c   Olshansky, S Jay ^d   Perls, Thomas T ^e   Rothman, David J ^f   Rothman, Sheila M ^f   Warner, Huber R ^g   West, Michael D ^h   Wright, Woodring E ⁱ  

^a International Longevity Center   (United States)

^b Journal of Anti Aging Medicine   (United States)

^c Kronos Longevity Research Institute   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e BOSTON MEDICAL CENTER   (United States)

^f Columbia University ^*  (United States)

^g NATIONAL INSTITUTE ON AGING   (United States)

^h Advanced Cell Technology   (United States)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; ESTROGEN; GROWTH HORMONE; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MELATONIN; PRASTERONE; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; TELOMERASE; UNCLASSIFIED DRUG;

AGING; ANTIOXIDANT ACTIVITY; CALORIC INTAKE; CANCER INCIDENCE; CIGARETTE SMOKING; DIET RESTRICTION; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; GROWTH HORMONE DEFICIENCY; HEART FAILURE; HORMONE SUBSTITUTION; HUMAN; LIFE EXPECTANCY; LONGEVITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIDE EFFECT; SMOKING CESSATION; STEM CELL TRANSPLANTATION; TELOMERE;

AGING; ANIMALS; HUMANS;

ANIMALIA; DROSOPHILA MELANOGASTER; MAMMALIA; NEMATODA;

EID: 0013320090     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/57.9.B333     Document Type: Review

References (51)

1. Calories and aging alter gene expression for gluconeogenic, glycolytic, and nitrogen-metabolizing enzymes
2. Calorie restriction in nonhuman primates: Mechanisms of reduced morbidity and mortality
3. Gene expression profile of aging and its retardation by caloric restriction
4. Effects of caloric restriction on skeletal muscle mitochondrial proton leak in aging rats
5. A conserved regulatory system for aging
6. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production
7. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
8. Antioxidant vitamin intake and coronary mortality in a longitudinal population study
9. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
10. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS)
11. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Vitamin E supplementation and cardiovascular events in highrisk patients
12. Life span extension and cancer risk: Myths and reality
13. Can antioxidant vitamins materially reduce oxidative damage in humans?
14. Extension of life-span with superoxide dismutase/catalase mimetics
15. Do plasma melatonin concentrations decline with age?
16. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
17. Melatonin increases both life span and tumor incidence in female CBA mice
18. Hormone replacement therapy and cognition-systematic review and meta-analysis
19. Reduced mortality associated with long-term postmenopausal estrogen therapy
20. Postmenopausal hormone therapy and mortality
21. Cause-specific mortality in women receiving hormone replacement therapy
22. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study, a prospective, observational study
23. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
24. Hormonal therapy increases arterial compliance in postmenopausal women
25. Postmenopausal hormone-replacement therapy
26. Age-related changes in the twenty-four hour spontaneous secretion of growth hormone in normal individuals
27. Impaired growth hormone secretion in the adult population. Relation to age and adiposity
28. Plasma growth hormone during sleep in young and aged men
29. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients
30. Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults
31. Gender differences in the effects of long-term growth hormone (GH) treatment on bone in adults with GH deficiency
32. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density in growth hormone deficient adults without causing adverse effects
33. Effects of growth hormone in men over 60 years old
34. Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animals
35. Assessment of growth parameters and life span of GHR/BP gene disrupted mice
36. Prolonged longevity of hypopituitary dwarf mice
37. Extension of life span by introduction of telomerase into normal human cells
38. Longevity, stress response and cancer in aging telomerase-deficient mice
39. When do telomeres matter?
40. A telomerase component is defective in the human disease dyskeratosis congenita
41. Mammalian neural stem cells
42. NIH review outlines enormous promise
43. Embryonic stem cell lines derived from human blastocysts
44. Genetically selected cardiomyocytes form differentiating embryonic stem cells from intracardiac grafts
45. High hopes for the heart
46. Human therapeutic cloning
47. Extension of cell life-span and telomere length in animal cells cloned from senescent somatic cells
48. The ethical validity of using nuclear transfer in human transplantation
49. Program for testing biological interventions to promote healthy aging
50. Antiaging technology and pseudoscience